China enters CAR-T cell therapy era
Innovation (Camb)
.
2021 Dec 16;3(1):100197.
doi: 10.1016/j.xinn.2021.100197.
eCollection 2022 Jan 25.
Authors
Xin Cao
1
2
,
Wei Li
3
2
4
,
Yiyi Yu
3
2
5
,
Tianshu Liu
3
2
,
Yuhong Zhou
3
2
4
Affiliations
1
Institute of Clinical Science, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
2
Cancer Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
3
Department of Medical Oncology, Zhongshan Hospital Fudan University, Shanghai 200032, China.
4
Cell Therapy Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
5
Clinical Trial Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
PMID:
35072132
PMCID:
PMC8764468
DOI:
10.1016/j.xinn.2021.100197
No abstract available
Publication types
News